Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
75 year old man
HIV (antiretroviral therapy)
Severe chronic kidney disease(dialysis)
Ischaemic cardiomyopathy : past myocardial infarction 1991
Apical and subcoastal TTE views showing mild tricuspid regurgitation
Organic TR due to flail leaflet
Functional TR due to severe left side-disease
Functional TR due to the PM lead
Tricuspid endocarditis secondary to PM implantation
TTE should be performed before and after PM implantation
TOE may be performed for severe TR in order to identify the mechanism
In cases of severe symptomatic tricuspid regurgitation caused by the PM lead, percutaneous or surgical material extraction with tricuspid valve repair or replacement should be discussed, depending on TR mechanism
Guidelines on the management of valvular heart disease (version 2012), Vahanian et Al., European Heart Journal
Lead-induced severe tricuspid regurgitation is a rare but severe complication of pacemaker implantation
TTE should be systematically performed before and after PM implantation
Percutaneous or surgical material extraction with tricuspid valve repair or replacement should be discussed in cases of severe symptomatic tricuspid regurgitation caused by the PM